FDA Inspection 1306320 — Hospital of the Univ of PA-Reproductive Surgical Facility Penn Fertility Care
The FDA completed an inspection of Hospital of the Univ of PA-Reproductive Surgical Facility Penn Fertility Care on February 25, 2026 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 25, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Philadelphia, PA (United States)